NCT06405438 Comparison of the Efficacy of Peloid Therapy and Paraffin Treatment in Carpal Tunnel Syndrome
| NCT ID | NCT06405438 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Beylikduzu State Hospital |
| Condition | Carpal Tunnel Syndrome |
| Study Type | OBSERVATIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-10-10 |
| Primary Completion | 2025-01-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 60 participants in total. It began in 2024-10-10 with a primary completion date of 2025-01-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study compares the effectiveness of peloid therapy and paraffin treatment in carpal tunnel syndrome. Patients who have already received 2 weeks of peloid therapy or 15 sessions of paraffin treatment will be assessed. Pain and symptom severity are assessed using the Visual Analog Scale (VAS) and Boston Carpal Tunnel Syndrome Questionnaire (BCTQ). Electrophysiological examinations will also be conducted at the same time points: baseline, 4 weeks post-treatment, and a 12-week follow-up.
Eligibility Criteria
Inclusion Criteria: * Patients aged between 18 and 65 years old. * Patients diagnosed with mild to moderate carpal tunnel syndrome based on electrophysiological evaluations. * Patients experiencing symptoms for a minimum of 3 months. Exclusion Criteria: * Patients diagnosed with neuropathic conditions such as polyneuropathy, brachial plexopathy, or thoracic outlet syndrome. * Patients with a history of previous injections or surgery for carpal tunnel syndrome.
Contact & Investigator
Büşra Şirin Ahısha, MD
PRINCIPAL INVESTIGATOR
Beylikdüzü State Hospital
Frequently Asked Questions
Who can join the NCT06405438 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Carpal Tunnel Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06405438 currently recruiting?
Yes, NCT06405438 is actively recruiting participants. Contact the research team at bsrn080@gmail.com for enrollment information.
Where is the NCT06405438 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT06405438 clinical trial?
NCT06405438 is sponsored by Beylikduzu State Hospital. The principal investigator is Büşra Şirin Ahısha, MD at Beylikdüzü State Hospital. The trial plans to enroll 60 participants.